Tedros Adhanom Ghebreyesus (Denis Balibouse/Pool Photo via AP)
Covid-19 roundup: FDA greenlights Gilead's Veklury for outpatient use; WHO head warns world is primed for more variants
The FDA has added to the label of Gilead’s Veklury — previously approved only for hospitalized patients above the age of 12 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
